BAJAJ BROKING
A joint venture was formed by Nestle India and Dr Reddy’s to expand the reach of Nestle's nutritional solutions in India. Dr Reddy’s will hold a 51% stake initially, with Nestle India retaining the rest and the option to increase its shareholding later. JV will licence specific brands including Nature's Bounty and Rebalanz and likely commence operating in the second quarter of FY25.
Nestle India and Dr Reddy’s Laboratories have joined forces to establish a joint venture aimed at broadening the availability of Nestle's global nutritional health solutions across India. The JV represents a unique approach to promoting good health.
Additional Read: Share Market News
This strategic partnership will see Dr Reddy’s holding a majority stake of 51%, allowing Nestle India to leverage their established retail and distribution network to reach more consumers nationwide.
The joint venture will facilitate the licensing of renowned brands from both companies, including Nature's Bounty and Rebalanz, catering to various nutritional and over-the-counter segments.
By pooling their resources and expertise, Nestle and Dr Reddy’s aim to introduce innovative nutraceutical brands that promote healthier lifestyles and meet the evolving needs of consumers in India.
With operations set to commence in the second quarter of FY25, the joint venture is poised to enhance access and affordability of nutritional health solutions in India.
By combining Nestle Health Sciences’ global portfolio with Dr Reddy’s commercial capabilities, the partnership seeks to make a meaningful difference in improving the quality of life for consumers, underscoring their shared commitment to promoting good health and well-being.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Sources:
https://economictimes.indiatimes.com/industry/
cons-products/fmcg/nestle-dr-reddys-to-form-jv-to-market-nutraceutical-brands-in-india/articleshow/109590322.cms?from=mdr
https://www.moneycontrol.com/news/business
/earnings/nestle-india-to-form-jv-with-dr-reddys-for-nutritional-health-solutions-12708136.html
Share this article:
Nifty Healthcare Index
14 Dec, 2024 | 5 Min. read
Standard Deviation: Meaning, How To Use and Calculate
14 Dec, 2024 | 5 Min. read
Business Forecasting: Definition, Methods, and Models
14 Dec, 2024 | 8 Min. read
Modern Portfolio Theory (MPT): Definition, Types & How To Use
14 Dec, 2024 | 8 Min. read
ASM & GSM Meaning - List of ASM & GSM Stocks
14 Dec, 2024 | 7 Min. read
Bollinger Bands: Meaning, How To Interpret and Use
14 Dec, 2024 | 7 Min. read
Hedging: Meaning, Types, Risks and Strategie
14 Dec, 2024 | 6 Min. read
Moving Averages Indicator: Variations & Examples
13 Dec, 2024 | 4 Min. read
Learn Everything About Breakout Trading
13 Dec, 2024 | 8 Min. read
Gold Price in India | Gold Drops 1% After Reaching Five-Week High
13 Dec, 2024 | 39 Min. read
Statement of Account and Demat Account: Meaning & Differences
13 Dec, 2024 | 4 Min. read
What are the Timing For Commodity Market Trading?
13 Dec, 2024 | 6 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading